NEW YORK (Reuters Health) – Not all patients with elevated intraocular pressure (IOP) need pressure-reducing treatment to prevent glaucoma-related vision […]
Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in […]